Cardiff Oncology Stock Price on December 4, 2024

CRDF Stock  USD 2.41  0.18  6.95%   
Below is the normalized historical share price chart for Cardiff Oncology extending back to July 27, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cardiff Oncology stands at 2.41, as last reported on the 5th of December, with the highest price reaching 2.58 and the lowest price hitting 2.40 during the day.
IPO Date
27th of July 2004
200 Day MA
3.1238
50 Day MA
2.8298
Beta
1.928
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Cardiff Stock, it is important to understand the factors that can impact its price. Cardiff Oncology appears to be very risky, given 3 months investment horizon. Cardiff Oncology secures Sharpe Ratio (or Efficiency) of 0.0657, which signifies that the company had a 0.0657% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cardiff Oncology, which you can use to evaluate the volatility of the firm. Please makes use of Cardiff Oncology's Downside Deviation of 7.24, mean deviation of 3.91, and Risk Adjusted Performance of 0.0492 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Cardiff Oncology's Common Stock Total Equity is most likely to increase significantly in the upcoming years. The Cardiff Oncology's current Preferred Stock Total Equity is estimated to increase to 1,208, while Liabilities And Stockholders Equity is projected to decrease to roughly 45.3 M. . At this time, Cardiff Oncology's Price To Sales Ratio is most likely to increase significantly in the upcoming years. The Cardiff Oncology's current Price Sales Ratio is estimated to increase to 201.15, while Price Earnings Ratio is projected to decrease to (1.68). Cardiff Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0657

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCRDF
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.8
  actual daily
51
51% of assets are less volatile

Expected Return

 0.38
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Cardiff Oncology is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiff Oncology by adding it to a well-diversified portfolio.
Price Book
2.6813
Enterprise Value Ebitda
(3.66)
Price Sales
179.1166
Shares Float
47.8 M
Wall Street Target Price
9.1575

Related Headline

Reviva Pharmaceuticals Headline on 4th of December 2024

Akebia Therapeutics and Reviva Pharmaceuticals are both small-cap medical companies, but which is the better business We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation. Risk Volatility Akebia Therapeutics has a

Cardiff Oncology Valuation on December 4, 2024

It is possible to determine the worth of Cardiff Oncology on a given historical date. On December 4, 2024 Cardiff was worth 2.58 at the beginning of the trading date compared to the closed value of 2.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardiff Oncology stock. Still, in general, we apply an absolute valuation method to find Cardiff Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardiff Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardiff Oncology's related companies.
 Open High Low Close Volume
  2.67    2.68    2.54    2.59    493,238  
12/04/2024
  2.58    2.58    2.40    2.41    857,681  
  2.58    2.58    2.40    2.41    0.00  
Backtest Cardiff Oncology  |  Cardiff Oncology History  |  Cardiff Oncology Valuation   PreviousNext  
Open Value
2.58
2.41
Closing Value
19.97
Upside

Cardiff Oncology Trading Date Momentum on December 4, 2024

On December 05 2024 Cardiff Oncology was traded for  2.41  at the closing time. The top price for the day was 2.58  and the lowest listed price was  2.40 . There was no trading activity during the period 0.0. Lack of trading volume on December 5, 2024 did not affect price variability. The overall trading delta against the current closing price is 7.05% .

Cardiff Oncology Fundamentals Correlations and Trends

By evaluating Cardiff Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardiff Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardiff financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cardiff Oncology Stock history

Cardiff Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardiff is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardiff Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardiff Oncology stock prices may prove useful in developing a viable investing in Cardiff Oncology
Last ReportedProjected for Next Year
Common Stock Shares Outstanding44.7 M46.9 M
Net Loss-34.9 M-36.6 M

Cardiff Oncology Quarterly Net Working Capital

46.81 Million

Cardiff Oncology Stock Technical Analysis

Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cardiff Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cardiff Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cardiff Oncology Period Price Range

Low
December 5, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Cardiff Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cardiff Oncology December 5, 2024 Market Strength

Market strength indicators help investors to evaluate how Cardiff Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiff Oncology shares will generate the highest return on investment. By undertsting and applying Cardiff Oncology stock market strength indicators, traders can identify Cardiff Oncology entry and exit signals to maximize returns

Cardiff Oncology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cardiff Oncology's price direction in advance. Along with the technical and fundamental analysis of Cardiff Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardiff to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Cardiff Stock analysis

When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk